Fortive: Accelerated Execution Amidst Early Tailwinds, Is Margin Durability the Next Strategic Unlock?

Fortive’s Q4 2025 results highlight early traction from its “Fortive Accelerated” strategy, with adjusted EPS of $0.90 (+13% Y/Y) bringing FY25 EPS to $2.71, modestly exceeding guidance and reflecting stronger operational discipline, portfolio focus, and accretive capital deployment rather than a sharp demand inflection. Core revenue growth of just over 3% alongside 8% EBITDA growth and margin expansion to roughly 32% underscores improving operating leverage and cost management. The Intelligent Operating Solutions (IOS) segment delivered ~4% core growth, supported by strength in Fluke and Industrial Scientific across data center and defense markets, improved international commercial coverage, and continued double-digit ARR growth in software offerings. Meanwhile, the Advanced Healthcare Solutions (AHS) segment remained softer, posting 1.6% core growth as hospital capital spending remained cautious, though recurring software and consumables demand remained resilient and management expects margin improvement as spending normalizes. Fortive also maintained strong capital discipline, generating ~$930M in free cash flow with conversion above 100% and repurchasing $1.3B of shares in the second half of the year. For FY26, management guides to EPS of $2.90–$3.00 with modest revenue growth and continued margin expansion, though execution will depend on sustained ARR momentum and a recovery in healthcare CapEx. If Fortive can continue expanding recurring software revenue while stabilizing healthcare demand, can the company unlock durable margin expansion sufficient to re-rate its valuation?